167 related articles for article (PubMed ID: 16139170)
1. SERT and DAT availabilities under citalopram treatment in obsessive-compulsive disorder (OCD).
Pogarell O; Poepperl G; Mulert C; Hamann C; Sadowsky N; Riedel M; Moeller HJ; Hegerl U; Tatsch K
Eur Neuropsychopharmacol; 2005 Oct; 15(5):521-4. PubMed ID: 16139170
[TBL] [Abstract][Full Text] [Related]
2. Serotonin transporter imaging with [123I]beta-CIT SPECT before and after one year of citalopram treatment of obsessive-compulsive disorder.
Stengler-Wenzke K; Müller U; Barthel H; Angermeyer MC; Sabri O; Hesse S
Neuropsychobiology; 2006; 53(1):40-5. PubMed ID: 16397403
[TBL] [Abstract][Full Text] [Related]
3. Changes in thalamus-hypothalamus serotonin transporter availability during clomipramine administration in patients with obsessive-compulsive disorder.
Zitterl W; Aigner M; Stompe T; Zitterl-Eglseer K; Gutierrez-Lobos K; Wenzel T; Zettinig G; Hornik K; Pirker W; Thau K
Neuropsychopharmacology; 2008 Dec; 33(13):3126-34. PubMed ID: 18354388
[TBL] [Abstract][Full Text] [Related]
4. Higher serotonin transporter availability in early-onset obsessive-compulsive disorder patients undergoing escitalopram treatment: A [
Lee J; Kim BH; Kim E; Howes OD; Cho KIK; Yoon YB; Kwon JS
Hum Psychopharmacol; 2018 Jan; 33(1):. PubMed ID: 29210107
[TBL] [Abstract][Full Text] [Related]
5. Reappraisal of spontaneous stereotypy in the deer mouse as an animal model of obsessive-compulsive disorder (OCD): response to escitalopram treatment and basal serotonin transporter (SERT) density.
Wolmarans de W; Brand L; Stein DJ; Harvey BH
Behav Brain Res; 2013 Nov; 256():545-53. PubMed ID: 24013013
[TBL] [Abstract][Full Text] [Related]
6. Serotonin and dopamine transporter availabilities correlate with the loudness dependence of auditory evoked potentials in patients with obsessive-compulsive disorder.
Pogarell O; Tatsch K; Juckel G; Hamann C; Mulert C; Pöpperl G; Folkerts M; Choukèr M; Riedel M; Zaudig M; Möller HJ; Hegerl U
Neuropsychopharmacology; 2004 Oct; 29(10):1910-7. PubMed ID: 15292904
[TBL] [Abstract][Full Text] [Related]
7. Serotonin and dopamine transporter imaging in patients with obsessive-compulsive disorder.
Hesse S; Müller U; Lincke T; Barthel H; Villmann T; Angermeyer MC; Sabri O; Stengler-Wenzke K
Psychiatry Res; 2005 Oct; 140(1):63-72. PubMed ID: 16213689
[TBL] [Abstract][Full Text] [Related]
8. Validation of [(123)I]beta-CIT SPECT to assess serotonin transporters in vivo in humans: a double-blind, placebo-controlled, crossover study with the selective serotonin reuptake inhibitor citalopram.
de Win MM; Habraken JB; Reneman L; van den Brink W; den Heeten GJ; Booij J
Neuropsychopharmacology; 2005 May; 30(5):996-1005. PubMed ID: 15770240
[TBL] [Abstract][Full Text] [Related]
9. Single photon emission computed tomography (SPECT) of anxiety disorders before and after treatment with citalopram.
Carey PD; Warwick J; Niehaus DJ; van der Linden G; van Heerden BB; Harvey BH; Seedat S; Stein DJ
BMC Psychiatry; 2004 Oct; 4():30. PubMed ID: 15482603
[TBL] [Abstract][Full Text] [Related]
10. Altered serotonin transporter binding potential in patients with obsessive-compulsive disorder under escitalopram treatment: [11C]DASB PET study.
Kim E; Howes OD; Park JW; Kim SN; Shin SA; Kim BH; Turkheimer FE; Lee YS; Kwon JS
Psychol Med; 2016 Jan; 46(2):357-66. PubMed ID: 26423910
[TBL] [Abstract][Full Text] [Related]
11. Dopamine transporter density in the basal ganglia in obsessive-compulsive disorder, measured with [123I]IPT SPECT before and after treatment with serotonin reuptake inhibitors.
Kim CH; Cheon KA; Koo MS; Ryu YH; Lee JD; Chang JW; Lee HS
Neuropsychobiology; 2007; 55(3-4):156-62. PubMed ID: 17657168
[TBL] [Abstract][Full Text] [Related]
12. Serotonin 2A receptor, serotonin transporter and dopamine transporter alterations in dogs with compulsive behaviour as a promising model for human obsessive-compulsive disorder.
Vermeire S; Audenaert K; De Meester R; Vandermeulen E; Waelbers T; De Spiegeleer B; Eersels J; Dobbeleir A; Peremans K
Psychiatry Res; 2012 Jan; 201(1):78-87. PubMed ID: 22285716
[TBL] [Abstract][Full Text] [Related]
13. Serotonin transporter binding in Tourette Syndrome.
Müller-Vahl KR; Meyer GJ; Knapp WH; Emrich HM; Gielow P; Brücke T; Berding G
Neurosci Lett; 2005 Sep; 385(2):120-5. PubMed ID: 15936877
[TBL] [Abstract][Full Text] [Related]
14. Serotonin transporters in dopamine transporter imaging: a head-to-head comparison of dopamine transporter SPECT radioligands 123I-FP-CIT and 123I-PE2I.
Ziebell M; Holm-Hansen S; Thomsen G; Wagner A; Jensen P; Pinborg LH; Knudsen GM
J Nucl Med; 2010 Dec; 51(12):1885-91. PubMed ID: 21078806
[TBL] [Abstract][Full Text] [Related]
15. In vivo imaging of serotonin transporter occupancy by means of SPECT and [123I]ADAM in healthy subjects administered different doses of escitalopram or citalopram.
Klein N; Sacher J; Geiss-Granadia T; Attarbaschi T; Mossaheb N; Lanzenberger R; Pötzi C; Holik A; Spindelegger C; Asenbaum S; Dudczak R; Tauscher J; Kasper S
Psychopharmacology (Berl); 2006 Oct; 188(3):263-72. PubMed ID: 16955282
[TBL] [Abstract][Full Text] [Related]
16. Displacement of serotonin and dopamine transporters by venlafaxine extended release capsule at steady state: a [123I]2beta-carbomethoxy-3beta-(4-iodophenyl)-tropane single photon emission computed tomography imaging study.
Shang Y; Gibbs MA; Marek GJ; Stiger T; Burstein AH; Marek K; Seibyl JP; Rogers JF
J Clin Psychopharmacol; 2007 Feb; 27(1):71-5. PubMed ID: 17224717
[TBL] [Abstract][Full Text] [Related]
17. A proton MRSI study of brain N-acetylaspartate level after 12 weeks of citalopram treatment in drug-naive patients with obsessive-compulsive disorder.
Jang JH; Kwon JS; Jang DP; Moon WJ; Lee JM; Ha TH; Chung EC; Kim IY; Kim SI
Am J Psychiatry; 2006 Jul; 163(7):1202-7. PubMed ID: 16816225
[TBL] [Abstract][Full Text] [Related]
18. Higher serotonin transporter occupancy after multiple dose administration of escitalopram compared to citalopram: an [123I]ADAM SPECT study.
Klein N; Sacher J; Geiss-Granadia T; Mossaheb N; Attarbaschi T; Lanzenberger R; Spindelegger C; Holik A; Asenbaum S; Dudczak R; Tauscher J; Kasper S
Psychopharmacology (Berl); 2007 Apr; 191(2):333-9. PubMed ID: 17235610
[TBL] [Abstract][Full Text] [Related]
19. Serotonin transporter occupancy by the SSRI citalopram predicts default-mode network connectivity.
Schrantee A; Lucassen PJ; Booij J; Reneman L
Eur Neuropsychopharmacol; 2018 Oct; 28(10):1173-1179. PubMed ID: 30082141
[TBL] [Abstract][Full Text] [Related]
20. Altered serotonin and dopamine transporter availabilities in brain of depressed patients upon treatment with escitalopram: A [123 I]β-CIT SPECT study.
Rominger A; Cumming P; Brendel M; Xiong G; Zach C; Karch S; Tatsch K; Bartenstein P; la Fougère C; Koch W; Pogarell O
Eur Neuropsychopharmacol; 2015 Jun; 25(6):873-81. PubMed ID: 25819144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
